Stopping Bisphosphonates Ups Hip Fracture Risk
Study findings may help guide rheumatologists plan long-term therapy for patients dealing with low bone mass.
3 New Things About Osteoporosis and Fractures
Both romosozumab and calcium help fracture prevention, and most young adults have fractures at nonosteoporotic sites.
Osteoporosis Drug Could Raise the Treatment Bar
In the ARCH trial, romosozumab plus alendronate outperformed alendronate alone in reducing fracture risk.
4 New Things About Osteoporosis
The latest research findings reveal new aspects of diagnosis, treatment, and prevention.
Osteoporosis Drug Costs Called Into Question
An ICER analysis and expert commentary on anabolics’ benefits and costs offer some opposing views, and some consensus.
Osteoporosis Pharmacotherapy Use Falls Short
Only a minority of postmenopausal women reported using appropriate therapy other than estrogen to reduce future fractures.
Romosozumab Continues to Build Bone, Reduce Fracture Risk
EULAR 2017: Romosozumab reduces the risk of clinical vertebral fractures in postmenopausal women with osteoporosis by as much as five times.
15 Recommendations for Treating Glucocorticoid-Induced Osteoporosis
For the first time in seven years, the ACR has new treatment recommendations for glucocorticoid-induced osteoporosis. In this slideshow, we highlight the new guidelines.
Drug Roundup: New FDA-Approved Treatments in Rheumatology
In this slideshow, we offer a glance at newly approved treatments for rheumatoid arthritis, juvenile arthritis, osteoporosis and fingernail psoriasis, among other conditions.
Fragility Fractures in Men Associated with Greater Risk of Mortality
Elderly women are at higher risk of acquiring a fragility fracture than men, yet men are more likely to die from their injuries, researchers reported at AAOS 2017 this week.